About Vindhya Pharma (India) Private Limited
Data last updated:
Vindhya Pharma (India) Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Viyash Life Sciences Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 July 2006.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24296TG2006PTC050700. Its GSTIN is 36AACCV4158P1ZQ (Telangana). The company held 3 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.87 Cr. It was led by directors including Srinivas Vasireddy and Kalidindi Srihari Raju.
Its last annual general meeting (AGM) was held on 18 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Plot No.290 Srivalli'S Corporate Road No.6 Kakatiya Hills Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.89 Cr, a decline of 50% compared to the previous year. For the same year it recorded a net profit of ₹7.26 Cr (net margin 105.5%) and EBITDA of ₹7.83 Cr (EBITDA margin 113.6%). Revenue has declined at a compounded annual rate (CAGR) of 64% over three years and 58% over five years.
The company had about 49 employees on its provident fund (EPFO) records before it was dissolved. Its group structure included 1 subsidiary.
The company was associated with 1 brand: Vindhya Pharma. As per MCA filings, the company had open charges of ₹2 Cr and satisfied charges of ₹32.81 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 3 filed against it; 3 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹1.81 Cr; the latest was in June 2021. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Atharva Biopharma Private Limited with revenue of ₹7.23 Cr.
The last known website on record is vindhyapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.290 Srivalli'S Corporate Road No.6 Kakatiya Hills Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vindhya Pharma (India) Private Limited
The main business activities of Vindhya Pharma (India) are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and retail trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vindhya Pharma (India) Private Limited FY 2025 filings available
Vindhya Pharma (India) Private Limited reported revenue of ₹6.89 Cr (down 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Vindhya Pharma (India) Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 58% over five years, including a 50% fall in the latest year. EBITDA rose 183% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vindhya Pharma (India) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.83 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.26 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vindhya Pharma (India) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 113.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 105.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vindhya Pharma (India) are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atharva Biopharma Private Limited | ₹7.23 Cr (FY 2025) | •••• | •••• | 144350.0% | •••• | Pune, Maharashtra, India |
| Symphony Pharma Lifesciences Private Limited | ₹7.2 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Kolthur Village, Telangana, India |
| Bileshwar Pharmaceuticals Private Limited | ₹7.16 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Jhagadia, Gujarat, India |
| Gagangiri Pharma Chem Private Limited | ₹6.93 Cr (FY 2024) | •••• | •••• | 40.0% | •••• | Mumbai, Maharashtra, India |
| Dharoya Pharmaciuticales Pvt Ltd | ₹6.93 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Vadodara, Gujarat, India |
| Vindhya Pharma (India) Private Limited this company | ₹6.89 Cr (FY 2025) | •••• | •••• | -50.0% | •••• | Hyderabad, Telangana, India |
| Mediff Pharma Private Limited | ₹6.8 Cr (FY 2025) | •••• | •••• | 204.0% | •••• | New Delhi, Delhi, India |
| Cospharm Speciality Ingredients Private Limited | ₹6.77 Cr (FY 2024) | •••• | •••• | 47.0% | •••• | Pune, Maharashtra, India |
| Anant Pharmaceuticals Private Limited | ₹6.76 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Ambernath East, Maharashtra, India |
| HTS Biopharma Private Limited | ₹6.71 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Hyderabad, Telangana, India |
| Abhinandan Rasayan Private Limited | ₹6.66 Cr (FY 2018) | •••• | •••• | -37.0% | •••• | Dombivli East, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Vindhya Pharma (India) by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) Private Limited is audited by Deloitte Haskins & Sells for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivas Vasireddy Also directs: Viyash Scientific Limited, Alivira Animal Health Limited | Director | 12 May 2023 | 3 Years 4 Months | As last reported |
| Kalidindi Srihari Raju Also directs: Pokepola Enterprises LLP | Director | 16 Sep 2019 | 7 Years 0 Months | As last reported |
| Hari Babu Bodepudi Also directs: Viyash Scientific Limited | Director | 16 Sep 2019 | 7 Years 0 Months | As last reported |
Ownership and Shareholding of Vindhya Pharma (India) Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vindhya Pharma (India) Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Nov 2020 | Others | ₹48.12 Lakh | Satisfied |
| 27 May 2020 | Others | ₹6.5 Cr | Satisfied |
| 18 Dec 2019 | Hdfc Bank Limited | ₹7.95 Cr | Satisfied |
| 15 Feb 2019 | Others | ₹92.7 Lakh | Satisfied |
| 26 Feb 2011 | Axis Bank Limited | ₹7.5 Cr | Satisfied |
Total charge records: 6 View all charges
Deals & Funding of Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) Private Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹1.81 Cr; the latest was in June 2021.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: Viyash Life Sciences Private Limited Seller: 2 individuals |
| Nov 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: Viyash Life Sciences Private Limited Seller: 3 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2008 | Funding round | ₹1.81 Cr | Investors: 2 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) Private Limited has 7 court cases on record: 2 filed by Vindhya Pharma (India), 3 filed against it, 2 where it is another party. 3 cases are pending and 4 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 1 | 2 |
| District courts | 3 | 2 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Visakapatnam, Andhra Pradesh | Court case (CEP) | Filed by the company against Vinta Laboratories Private Limited and 1 other | Disposed |
| High Court for State of Telangana | Court case (ITTA) | Filed against the company by Principal Commissioner of Income Tax - II | Pending |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by an individual | Pending |
| High Court for State of Telangana | Criminal complaint | Company is another party | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by Pioneer Chemical Industries | Disposed |
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) operates one associated brand: Vindhya Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality APIs and intermediates for the pharmaceutical industry. | vindhyapharma.com |
Employees and EPFO Compliance at Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) Private Limited has a workforce of 49 employees as of Mar 27, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| S.V. Labs Private Limited | U24239TG2003PTC041662 | Locked |
Showing major subsidiaries. Total: 1.
CIN History of Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) has one previous CIN (Corporate Identification Number): U24296AP2006PTC050700. The current CIN is U24296TG2006PTC050700, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24296TG2006PTC050700 | Current |
| U24296AP2006PTC050700 | Previous |
Recent Activity on Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) Private Limited has 11 board changes on record since 2010: 3 appointments and 8 cessations. The latest: Srinivas Vasireddy ceased to be Additional Director on 29 Sep 2023.
17 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vindhya Pharma (India) Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vindhya Pharma (India) Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vindhya Pharma (India) Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCV4158P1ZQ | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vindhya Pharma (India) Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vindhya Pharma (India) Private Limited
Vindhya Pharma (India) has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Vindhya Pharma (India) was a private limited company based in Hyderabad, Telangana, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 24 July 2006 and is registered under CIN U24296TG2006PTC050700. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Vindhya Pharma (India) was incorporated on 24 July 2006. It is registered with the Registrar of Companies, Hyderabad.
Vindhya Pharma (India) had 3 directors:
- Srinivas Vasireddy - Director
- Kalidindi Srihari Raju - Director
- Hari Babu Bodepudi - Director
The CIN (Corporate Identification Number) of Vindhya Pharma (India) is U24296TG2006PTC050700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Vindhya Pharma (India) is at Plot No.290 SrivalliS Corporate Road No.6 Kakatiya Hills Madhapur, Hyderabad, Telangana, India – 500081.
Vindhya Pharma (India) can be reached through the website vindhyapharma.com. Its registered office is in Hyderabad, Telangana, India.
Vindhya Pharma (India) reported revenue of ₹6.89 Cr for FY 2025 (down 50% YoY).
Vindhya Pharma (India) has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.87 Cr.
Vindhya Pharma (India) reported a net profit of ₹7.26 Cr (net margin 105.5%) and EBITDA of ₹7.83 Cr (EBITDA margin 113.6%) for FY 2025, as per its filed financial statements.
The GSTIN of Vindhya Pharma (India) is 36AACCV4158P1ZQ, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.